Last reviewed · How we verify

NCT03553693: RAPID-VL

Rapid HIV Viral Load Monitoring in High Risk Patients In Uganda

Completed NA Last updated 30 March 2021
What this trial tests

NA trial testing RAPID-VL study intervention in HIV in 2,443 participants. Completed in 16 November 2020.

Timeline
16 July 2018
Primary endpoint
16 November 2020
16 November 2020

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment2,443
Start date16 July 2018
Primary completion16 November 2020
Estimated completion16 November 2020
Sites1 location across Uganda

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

2 and older, any sex, with HIV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The RAPID-VL study will take place in 20 HIV care health facilities in Southwestern Uganda. The study will test the hypothesis that a multi-component intervention package that targets barriers to efficient and timely HIV viral load (VL) testing will improve test ordering, speed up result turnaround times, and improve the quality of VL results counseling to patients. Phase 1 of the study will consist of a 1-year retrospective medical record review in all participating health facilities. In Phase 2 the intervention will be introduced in 10 randomly chosen health facilities, while the remaining 10 sites will continue with standard VL testing and counseling operations. The study will measure the speed and efficiency of VL testing, experiences of patients and clinicians with the intervention, and the cost of the intervention.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.
    Drain PK, Dorward J, Bender A, Lillis L, et al · · 2019 · cited 103× · PMID 31092508 · DOI 10.1128/cmr.00097-18
  2. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial.
    Drain PK, Dorward J, Violette LR, Quame-Amaglo J, et al · · 2020 · cited 91× · PMID 32105625 · DOI 10.1016/s2352-3018(19)30402-3
  3. Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities.
    Ochodo EA, Olwanda EE, Deeks JJ, Mallett S. · · 2022 · cited 18× · PMID 35266555 · DOI 10.1002/14651858.cd013208.pub2

Verify or expand the search:

Other recruiting trials for HIV

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03553693.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing